Related references
Note: Only part of the references are listed.Pathogenesis of the erythroid failure in Diamond Blackfan anaemia
Colin A. Sieff et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia
Barbara Seliger et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis
Ayalew Tefferi et al.
LEUKEMIA RESEARCH (2009)
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Mark A. Dawson et al.
NATURE (2009)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt et al.
BLOOD (2008)
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
Isabelle Plo et al.
BLOOD (2008)
Cytogenetic studies at diagnosis in polycythemia vera:: clinical and JAK2V617F allele burden correlates
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray
Norihiko Kawamata et al.
EXPERIMENTAL HEMATOLOGY (2008)
p53 mrNA controls p53 activity by managing Mdm2 functions
Marco M. Candeias et al.
NATURE CELL BIOLOGY (2008)
Inhibition of the Bcl-xL Deamidation Pathway in Myeloproliferative Disorders
Rui Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F
K. Shide et al.
LEUKEMIA (2008)
Chromatin structure regulates gene conversion
W. Jason Cummings et al.
PLOS BIOLOGY (2007)
Distinct roles of Mdm2 and Mdm4 in red cell production
Marion Maetens et al.
BLOOD (2007)
From mRNA metabolism to cancer therapy: Chronic myelogenous leukemia shows the way
Danilo Perrotti et al.
CLINICAL CANCER RESEARCH (2007)
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function
Katarzyna Jastrzebski et al.
GROWTH FACTORS (2007)
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
Gerlinde Wernig et al.
BLOOD (2006)
JAK2(V617F) expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
Catherine Lacout et al.
BLOOD (2006)
RGS 16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes
M Berthebaud et al.
BLOOD (2005)
Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
K Ishiguro et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin
M Takagi et al.
CELL (2005)
Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia
JT Reilly
SEMINARS IN ONCOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
P53′s double life:: transactivation-independent repression of homologous recombination
P Bertrand et al.
TRENDS IN GENETICS (2004)
BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination
S Sengupta et al.
EMBO JOURNAL (2003)
BCR/ABL activates mdm2 rnRNA translation via the La antigen
R Trotta et al.
CANCER CELL (2003)
N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders
S Tsurumi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
DNA substrate dependence of p53-mediated regulation of double-strand break repair
N Akyüz et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
p53 regulation of DNA excision repair pathways
ML Smith et al.
MUTAGENESIS (2002)
Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts
E Le Scolan et al.
ONCOGENE (2001)
Characterization of the 5′ and 3′ untranslated regions in murine mdm2 mRNAs
SM Mendrysa et al.
GENE (2001)
Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: Role of La autoantigen in XIAP translation
M Holcik et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Analysis of mechanisms involved in the prevention of γ irradiation-induced apoptosis by hGM-CSF
R Liu et al.
ONCOGENE (2000)
Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia
M Zhou et al.
LEUKEMIA (2000)
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
JJ Michiels et al.
LEUKEMIA & LYMPHOMA (2000)
Share Paper
